Key result
An increase in serum BNP at hospital discharge compared to admission in patients with acute decompensated heart failure was independently associated with a significantly higher risk of 6-month all-cause mortality (HR 34.49).
Why the study?
Does an increase in serum BNP between admission and discharge predict 6-month all-cause mortality in patients with acute decompensated heart failure?
Cohort (n=177)
No
Does an increase in serum BNP between admission and discharge predict 6-month all-cause mortality in patients with acute decompensated heart failure?
Hazard Ratio: 34.49 (95% CI 4.55–261.06)
p-value: p=0.001
An increase in BNP from admission to discharge in ADHF patients is a strong independent predictor of 6-month all-cause mortality and is associated with a higher degree of residual congestion.
Discharge BNP rise may flag higher-risk ADHF patients; leaves open whether BNP-guided therapy improves outcomes in prospective trials.
BACKGROUND: B-type natriuretic peptide (BNP) is regarded as a reliable predictor of outcome in patients with acute decompensated heart failure (ADHF). However, according to some scholars, a single isolated measurement of serum BNP at the time of hospital admission would not be sufficient to provide reliable prognostic information. METHODS: A retrospective study was carried out on patients hospitalized for ADHF, who had then undergone follow-up of at least 6 months, in order to see if there was any difference in midterm mortality among patients with rising BNP at discharge as compared to those with decreasing BNP at discharge. Medical records had to be carefully examined to divide the case records into two groups, the former characterized by an increase in BNP during hospitalization, and the latter showing a decrease in BNP from the time of admission to the time of discharge. RESULTS: Ultimately, 177 patients were enrolled in a retrospective study. Among them, 53 patients (29.94%) had increased BNPs at the time of discharge relative to admission, whereas 124 (70.06%) exhibited decreases in serum BNP during their hospital stay. The group with patients who exhibited BNP increases at the time of discharge had higher degree of congestion evident in the higher frequency of persistent jugular venous distention (odds ratio: 3.72; P = 0.0001) and persistent orthopnea at discharge (odds ratio: 2.93; P = 0.0016). Moreover, patients with increased BNP at the time of discharge had a lower reduction in inferior vena cava maximum diameter (1.58 ± 2.2 mm vs. 6.32 ± 1.82 mm; P = 0.001 (one-way ANOVA)). In contrast, there was no significant difference in weight loss when patients with increased BNP at discharge were compared to those with no such increase. A total of 14 patients (7.9%) died during the 6-month follow-up period. Cox proportional hazard analysis revealed that BNP increase at the time of discharge was an independent predictor of 6-month all-cause mortality after adjustment for age, sodium at discharge, creatinine at discharge and New York Heart Association (NYHA) class at discharge (hazard ratio 34.49; 95% confidence intervals: 4.55 - 261.06; P = 0.001). CONCLUSIONS: Among patients with recent ADHF, increased BNP at the time of discharge from the hospital entailed a higher grade of congestion and higher 6-month mortality.
No takes yet. Share an insight, caveat, or question.
Vecchis et al. (2016) conducted a cohort in Acute Decompensated Heart Failure (n=177). BNP increase at discharge relative to admission vs. BNP decrease at discharge relative to admission was evaluated on 6-month all-cause mortality (HR 34.49, 95% CI 4.55 - 261.06, p=0.001). An increase in serum BNP at hospital discharge compared to admission in patients with acute decompensated heart failure was independently associated with a significantly higher risk of 6-month all-cause mortality (HR 34.49).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: